Yesterday, the COVID-19 vaccine developed by the University of Oxford and AstraZeneca was approved for use in the UK’s vaccination programme. Today, China’s State Food and Drug Administration also gave conditional approval to a vaccine developed by Sinopharm.
By the end of 2020, national regulatory authorities have approved six vaccines for public use. There are three categories of them: conventional inactivated vaccines, mRNA vaccines and viral vector vaccines.
In the EU, Pfizer-BioNTech’s vaccine will be sold under the brand name “Comirnaty”. The meaning of “Comirnaty” is said to be a combination of the terms COVID-19, mRNA, community, and immunity. The name was developed by the naming agency Brand Institute.
For a pharma company, the vaccine brand name is an important intangible asset. Would there be any loophole in the brand protection strategy, such that the relevant domain name is left unregistered? Certainly no. We conducted a WHOIS search and found that：
- Pfizer Inc registered both comirnaty.com and comirnaty.net on 28 May 2020;
- Sinovac registered coronavac.cn on 24 March 2020;
- bbibpcorv.com was created on 10 June 2020;
- mrna1273.com was created on 25 February 2020;
- sputnikvaccine.com was created on 3 August 2020;
- azd1222.com was created on 21 May 2020.
Hope that 2021 will be a better year. Next, we continue to look at some of the personnel changes in the intelligence, investigation and consultancy industry. The information is obtained through our sources as well as research of LinkedIn, Glassdoor, corporate and news websites etc.
- We reported in November that…